Expert Opinion on Therapeutic Targets

Top Research Topics at Expert Opinion on Therapeutic Targets?

The primary areas of discussion in Expert Opinion on Therapeutic Targets are Cancer research, Immunology, Internal medicine, Cancer and Bioinformatics. In the journal, Carcinogenesis, Targeted therapy, Signal transduction and Metastasis are investigated in conjunction with one another to address concerns in Cancer research research. Research on Signal transduction presented in it concerns the broader topic of Cell biology.

Specifically, studies on Kinase are prevalent in the Cell biology works discussed. The overlapping concepts between Receptor and Pharmacology are the key highlights of Immunology study. Topics in Internal medicine explored in the journal were investigated in conjunction with research in Diabetes mellitus, Endocrinology, Oncology and Cardiology.

The main emphasis of Expert Opinion on Therapeutic Targets is the research on Cancer, emphasizing the topic of Cancer cell. While Bioinformatics is the focus of Expert Opinion on Therapeutic Targets, it also provided insights into the studies of microRNA and Disease. The study on Disease presented is investigated in conjunction with research in Neuroscience.

• Cancer research (24.34%)
• Immunology (23.92%)
• Internal medicine (17.48%)

What are the most cited papers published in the journal?

• Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy (498 citations)
• Targeting the EGFR signaling pathway in cancer therapy (481 citations)
• The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. (467 citations)

Research areas of the most cited articles at Expert Opinion on Therapeutic Targets:

The journal papers mainly tackle studies in Cancer research, Cancer, Immunology, Pharmacology and Cell biology. The most cited publications address concerns in Cancer which are intertwined with other disciplines, such as Apoptosis, Signal transduction and Bioinformatics. The study of Pharmacology in the journal articles encompasses disciplines such as Receptor, as well as fields such as Endocrinology, all of which overlap with one another.

What topics the last edition of the journal is best known for?

• Gene
• Internal medicine
• Cancer

The previous edition focused in particular on these issues:

The aim of Expert Opinion on Therapeutic Targets is to expand the discussion of research in Cancer research, Disease, Bioinformatics, Cancer and Clinical trial. Fibrosis, Targeted therapy and Immunotherapy are some topics wherein Cancer research research discussed in the journal have an impact. The studies on Bioinformatics discussed can also contribute to research in the domains of Autophagy, Multiple sclerosis, Epigenetics and Dementia.

The Cancer works featured in the journal incorporate elements from Extracellular matrix, Stroma and Glycan. Research in Clinical trial tackled falls within the umbrella of Internal medicine. The studies on Immunology discussed can also contribute to research in the domains of Global population and Kinase.

The most cited articles from the last journal are:

• Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2. (15 citations)
• Autoimmune encephalitis: novel therapeutic targets at the preclinical level. (5 citations)
• The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Expert Opinion on Therapeutic Targets (based on the number of publications) are:

• Stamatios Theocharis (20 papers) absent at the last edition,
• Sheila A Doggrell (15 papers) absent at the last edition,
• Sabina A Antoniu (12 papers) absent at the last edition,
• Dong-Qing Ye (11 papers) absent at the last edition,
• Hai-Feng Pan (11 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Opinion on Therapeutic Targets (based on the number of publications) are:

• National and Kapodistrian University of Athens (40 papers) absent at the last edition,
• National Institutes of Health (34 papers) absent at the last edition,
• University of Texas MD Anderson Cancer Center (30 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Harvard University (27 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Anhui Medical University (19 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.81% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.17% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.78% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.17% of all publications and 72.88% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Overview of Predominant Study Fields and Application

Expert Opinion on Therapeutic Targets predominantly focuses its research on Cancer studies, Immunology, Internal Medicine, and Bioinformatics. In the arena of Cancer research, aspects such as Carcinogenesis, Targeted therapy, Signal transduction, and Metastasis are unraveled to gain further comprehension of the ailment. With respect to Internal Medicine, studies of paramount importance are researched upon. These include Diabetes mellitus, Endocrinology, Oncology and Cardiology. Understanding the complexities of these fields can pave the way for groundbreaking discoveries and innovations, especially in the fields of Therapeutics and treatment modalities.

In fact, many of the principles that this journal enshrines translate well into more vocationally oriented programs, like Licensed Practical Nurse (LPN) training. As healthcare practitioners closely adorned to patient care and treatments, LPNs can particularly benefit from these research studies in their practice. There are a wealth of high-quality LPN programs to consider. One notable place for such education is South Dakota; more specifically, students can find several quality-ensured education programs like lpn programs south dakota.

The utility of knowledge gained from such well-executed research can be eminently beneficial in a plethora of other fields as well. Whether it be Pharmacology, Cell biology, or Bioinformatics, the implications of research findings from Expert Opinion on Therapeutic Targets journal can be profoundly significant. In conclusion, Expert Opinion on Therapeutic Targets is a leading contributor in disseminating crucial research findings in the backdrop of Therapeutic Targets. It paints a comprehensive picture of the current state of these fields, providing valuable insights for budding researchers and established scholars alike.